Michael Mortimore - Concepedia

Author

Michael Mortimore

The University of Texas at Austin

Also Known As

M Mortimore, M. MORTIMORE, M. Mortimore, Michael M. P. Mortimore, Michael Mortimore

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas at Austin Vertex Pharmaceuticals (United Kingdom)Loughborough University University of Southampton AstraZeneca (United Kingdom)

About

Michael Mortimore is an author at The University of Texas at Austin specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	6	6	585
2	Medicine	5	5	507
3	Biochemistry	3	3	123
4	Engineering	1	1	31
5	Biomolecular Engineering	1	1	59

Michael Mortimore

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents Jean‐Damien Charrier, Steven J. Durrant, Julian M.C. Golec, Journal of Medicinal Chemistry Chemoprevention StrategyMolecular BiologyMolecular PharmacologyRad3 RelatedCancer Cell Biology	2011	256
Biogenetically Inspired Approach to the <i>Strychnos </i>Alkaloids. Concise Syntheses of (±)-Akuammicine and (±)-Strychnine Masayuki Ito, Cameron W. Clark, Michael Mortimore, Journal of the American Chemical Society	2001	159
Characterization of a selective and potent antagonist of human P2X<sub>7</sub>receptors, AZ11645373 Leanne Stokes, Lin‐Hua Jiang, Lindsay B. Alcaraz, British Journal of Pharmacology	2006	130
The discovery of the potent aurora inhibitor MK-0457 (VX-680) David Bebbington, Hayley Binch, Jean‐Damien Charrier, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryMedicineNatural SciencesMechanism Of Action	2009	99
Unified strategy for synthesis of indole and 2-oxindole alkaloids Stephen F. Martin, J. E. Hunter, B. BENAGE, Journal of the American Chemical Society Bioorganic ChemistryNatural SciencesAltmetric Attention ScoreOrganic ChemistrySocial Media Presence	1991	87
A Biomimetic Approach to the <i>Strychnos </i>Alkaloids. A Novel, Concise Synthesis of (±)-Akuammicine and a Route to (±)-Strychnine Stephen F. Martin, Cameron W. Clark, Masayuki Ito, Journal of the American Chemical Society Concise SynthesisBioorganic ChemistryBiochemistryNatural SciencesA Novel	1996	59
Discovery of Potent and Selective Adamantane-Based Small-Molecule P2X<sub>7</sub>Receptor Antagonists/Interleukin-1β Inhibitors Mark Furber, Lilian Alcaraz, Janice Bent, Journal of Medicinal Chemistry Rat P2x7 ReceptorImmunologyPharmacotherapyChemical BiologyHuman P2x7 Receptor	2007	58
Novel P2X7 receptor antagonists Lilian Alcaraz, Andrew Baxter, Jos Bent, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineMechanism Of ActionReceptor (Biochemistry)Pharmacological Agent	2003	58
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis Peter Weber, Ping Wang, Stéphane Maddens, Critical Care	2009	43
New methods for the synthesis of oxindole alkaloids. Total syntheses of isopteropodine and pteropodine. Stephen F. Martin, Michael Mortimore Tetrahedron Letters BiochemistryOrganic ChemistryNew MethodsSynthetic ChemistryTotal Syntheses	1990	38

Page 1